The aim of the present study was to measure plasma amino acid profiles in patients with staged cancers of the gastrointestinal tract; to attempt to relate possible changes in amino acid concentration to loss of weight and to note the effect of surgical removal of the tumour. Comparisons were made with a group of normal adult subjects and with a group of malnourished patients, but without eviAddress for correspondence: Mr R E Glass, MS, FRCS, The London Hospital, Whitechapel, London El 1BB.
mean±SEM) and without weight loss (66.8±4-1 [tmol/l) when compared both with patients with benign weight loss (34.6±3.2 tmol/1) and with control patients (48 2±3 5 [tmol/l) (p<O0O5).
In patients with cancer subjected to surgery the concentration of arginine (76-4±7-5 ,umol/l) fell to normal levels eight weeks after operation and remained normal 12 weeks after surgery (48.6±4-4 [tmol/l) (p<005). This was in contrast with the rise in plasma arginine in patients with pyloric stenosis after surgery, suggesting that the raised level of arginine was due to the presence of the primary tumour.
Patients with tumours of the gastrointestinal tract usually lose weight. Whether this is because of reduced dietary intake or specific metabolic changes induced in the host by the presence of the tumour is a subject of debate.
Clarke et al' in a study of amino acid levels in peripheral venous blood showed that patients with cancer and weight loss had amino acid patterns that were significantly different from patients who were malnourished for other reasons. Patients in this study were, however, suffering from a variety of neoplastic conditions, including cancer of the lung, breast, and lymphoreticular system.
The aim of the present study was to measure plasma amino acid profiles in patients with staged cancers of the gastrointestinal tract; to attempt to relate possible changes in amino acid concentration to loss of weight and to note the effect of surgical removal of the tumour. Comparisons were made with a group of normal adult subjects and with a group of malnourished patients, but without evi-dence of malignant disease. Patients with pyloric stenosis from peptic ulcer were included in the malnourished group and were similarly studied after corrective surgery.
Methods

PATIENTS
Fifty three patients (34 men and 19 women) with cancer of the gastrointestinal tract were studied; three with squamous cell carcinoma of the oesophagus, 18 with adenocarcinoma of the stomach and 32 with adenocarcinoma of the rectum or colon. Of this group 41 patients had lost weight.
Twelve patients (seven men and five women) who had lost weight from non-malignant, non-septic conditions were studied for comparison; six with pyloric stenosis from peptic ulcer, two with a short bowel from previous small bowel resection, and four who had lost weight with psychological anorexia. Twenty one patients admitted for elective treatment of non-malignant and minor surgical conditions were studied as controls.
In those patients with malignant disease the extent of spread of the tumour was assessed from 844 the findings at laparotomy and histological examination of the specimens removed. Of 53 patients with malignant disease 34 had tumours removed with the prospect of cure in that there was no evidence of metastases or residual tumour at surgery.
A group of 16 patients was restudied eight and 12 weeks after successful removal of the primary tumour; one with cancer of the oesophagus, two with cancer of the stomach and 14 with cancer of the colon or rectum. The growth was confined to the bowel in two patients, had spread outside the bowel in 14 patients, of which eight had tumours that had spread into local lymph glands. Six patients with pyloric stenosis from peptic ulceration were similarly studied after surgery.
AMINO ACID ANALYSIS
A sample of venous blood was taken after an overnight fast with the patient rested in bed. The plasma was separated by centrifugation. The concentration of 21 amino acids in the venous plasma was measured with a Locarte Amino Acid Analyser with an internal standard of norleucine (Sigma Chemical Co).
ANTHROPOMORPHIC ASSESSMENT
The fat mass and lean body mass in those patients who had lost weight was estimated with Harpenden skin fold calipers.2 There is a close correlation between fat free mass and lean body mass, as measured by total body potassium and fat free mass was taken to represent lean body mass in each subject.
The pre-illness weight of each patient and length of disease in weeks was recorded at patient interview. The height of the patient, their age, and preillness weight were substituted in the regression equations of Goode and Hawkins3 to predict the pre-illness lean body mass in each subject. Preillness fat mass was taken to be the difference between predicted lean body mass and the preillness weight. The difference between pre-illness and present total weight, lean body mass and fat mass was expressed as percentage change, and from the duration the rate of change calculated and expressed as percentage change per week.
STATISTICAL METHODS
The statistical method used to compare the concentration of amino acids in the various groups of patients was a one-way analysis of variance using logs of the data when the distribution was positively skewed. In addition, the Student-Newman-Keuls procedure was used to adjust for making multiple comparisons between groups. [tmol/l) when compared with patients with localised tumours (72.7±4.6 p.mol/l). Glass, Goode, Houghton, and Rowell In 16 patients studied eight weeks after the removal of the primary tumour, there was a significant fall in the concentration of the amino acids arginine, serine, asparagine, leucine, and threonine when compared with pre-operative levels in the same patients (p<0-05 Wilcoxon's signed rank test) (Fig. 1) . When restudied 12 weeks after operation, the plasma concentration of arginine (48-6±4-4
[tmoUl) was significantly lower than the pre-operative level (76.4±7.5 ,umol/l) (p<0-05). There was no significant difference between the concentration of threonine, serine, asparagine, and leucine 12 weeks after operation when compared with pre-operative values measured in the same patients. Figure 2 shows the significant changes in amino acid concentration that occurred in six patients with pyloric stenosis when studied eight and 12 weeks after corrective surgery. Although the concentration of amino acids measured eight weeks after corrective surgery was not significantly different from preoperative values, when restudied 12 weeks after operation the concentration of the amino acids In the present study the concentration of the majority of amino acids in the blood of patients who had lost weight was similar to the pattern typically seen in patients with chronic malnutrition. 4 The concentration of the amino acid arginine was, however, raised in patients with gastrointestinal cancer, and this was in contrast with the low levels of arginine measured in patients with benign disease. When the tumour was removed the concentration returned to normal levels. It would appear, therefore, that the raised levels of arginine in the blood of these patients was due to the presence of the primary tumour.
This abnormality is difficult to explain; the other urea cycle amino acids were normal and no patient had a raised blood urea. Arginine levels have been reported as being low in starvation in bacteraemia8 and in sepsis.6 A transient rise is seen after refeeding severely malnourished patients,4 but this is unlikely to have been the mechanism in the patients in this study. There is evidence to suggest that arginine stimulates tumour growth,9 "' and the action of the enzyme arginase has been reported to be very high in tumours of non-hepatic tissue.1 Attempts have been made to use arginase as a cytotoxic agent to lower the level of arginine in tissues and to inhibit tumour growth.'2 More recently Currie13 showed that macrophages killed tumour cells in vitro by releasing arginase, and that the cytotoxic activity could be prevented by the addition of arginine.
These observations are of obvious interest, but a discussion as to the role of arginase and arginine in the patients studied in this investigation must remain speculative. The results of this study do suggest, however, that arginine metabolism in patients with cancer of the gastrointestinal tract merits further study. 
